Abstract:Background: Lung cancer is one of the world's main health issues, and the exploration of novel protein markers can help to understand the mechanisms of lung cancer development and the discovery of therapeutic targets. Based on this, we used proteome-wide Mendelian Randomization to determine causal associations between plasma protein levels and the risk of developing lung cancer and subtypes. Methods: We performed a two-sample Mendelian Randomization analysis using genome-wide association data for 4907 proteins from the deCODE genetics study and five lung cancer and its subtypes from the FinnGen database. Causal effects were estimated using the Wald-ratio method or the inverse variance weighted (IVW) method, with additional analyses using the other four common methods when the number of SNPs was more than one. The Steiger filter method was used to test the correct direction of the causal effect. Multiple corrections were utilized by the Benjamini-Hochberg method. Results: After filtering, we finally analyzed 4645 proteins for the causal association with lung cancer, and the F-statistic of the instrumental variable for each protein was more than 10. After multiple tests, the levels of four genetically predictive proteins were found to be associated with the risk of lung cancer, and one protein was associated with the risk of small-cell lung cancer. In detail, elevated levels of three genetically predicted proteins were significantly associated with increased risk of lung cancer, namely, SYSC (OR:4.75, 95%CI: 2.47-9.16, FDR=0.007), TM11D (OR: 1.34, 95%CI: 1.17-1.53, FDR=0.02), and PDC6I (OR: 2.35, 95%CI: 1.58-3.49, FDR=0.03). Elevated levels of FASLG (OR: 0.87, 95%CI: 0.82-0.92, FDR=0.007) were associated with a reduced risk of lung cancer. In addition, genetically predicted elevated levels of GRP (OR: 0.05, 95%CI: 0.01-0.17, FDR=0.02) were associated with an increased risk of small-cell lung cancer. The Steiger filter test showed that all directions were from proteins to lung cancer. Conclusion: In this study, we found that five proteins may have effects on the risk of lung cancer, in which genetically predicted SYSC, TM11D, and PDC6I were significantly associated with an increased risk of lung cancer, whereas FASLG and GRP were associated with a decreased risk of lung cancer and small-cell lung cancer, respectively. The above may help to explore the pathogenesis of lung cancer, but further comprehensive studies are still needed. Citation Format: Guojin Si, Wenxuan Li, Yacong Zhang, Zhangyan Lyu, Fengju Song, Kexin Chen. Proteome-wide mendelian randomization identifies causal association between plasma proteins and lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 784.

Genetic overlap and causal inferences between diet-derived antioxidants and small-cell lung cancer

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Exploration of Lung Cancer-Related Genetic Factors via Mendelian Randomization Method Based on Genomic and Transcriptomic Summarized Data

Causal role of metabolites in non-small cell lung cancer: Mendelian randomization (MR) study

Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer

The causal association between serum metabolites and lung cancer based on multivariate Mendelian randomization

Exploration of kiwi root on non-small cell lung cancer based on network pharmacology and molecular docking

Lung Cancer Susceptibility and Risk Assessment Models

Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls

Abstract 809: Dietary Iron Intake, Genetic Variants in Microrna Related Iron Regulatory Pathway Genes, and the Risk of Non-Small Cell Lung Cancer

Abstract 784: Proteome-wide mendelian randomization identifies causal association between plasma proteins and lung cancer

Illuminating Shared Genetic Associations Between Oesophageal Carcinoma and Pulmonary Carcinoma Risk

Population Attributable Fraction of Lung Cancer Due to Genetic Variants, Modifiable Risk Factors, and Their Interactions: a Nationwide Prospective Cohort Study

Comparative Study of the Genomic Landscape and Tumor Microenvironment among Large Cell Carcinoma of the Lung, Large Cell Neuroendocrine of the Lung, and Small Cell Lung Cancer

Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk

An Update on Potential Molecular Biomarkers of Dietary Phytochemicals Targeting Lung Cancer Interception and Prevention

Role of the XPC Gene Expression in the Prevention of Oxidative and DNA Damage to Lung Squamous Carcinoma Cells

Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer

Potential Impact of Cancer Susceptibility Genes on Lung Cancer Metastasis

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma